Calciphylaxis, commonly known as calcific uremic arteriolopathy (CUA), is an end-stage renal disease (ESRD) illness. The syndrome results in necrotic skin ulcers, which are typically fatal. CUA is an uncommon but substantial source of morbidity and mortality in people with chronic renal disease, according to Rogers and Coates in 2008. CUA is becoming more common in individuals with renal failure, and it is increasingly being detected in patients who are not uremic.
Calciphylaxis Treatment, which begins with calcification of small peripheral veins that quickly expands, affects up to 4% of dialysis patients. It begins with the calcification of small peripheral vessels and spreads throughout the body swiftly. Furthermore, persons with calciphylaxis have a calcium metabolism imbalance, which causes calcium to be deposited in arterioles, finally resulting in blood clots in the arterioles. Fat tissues and skin can be deprived of oxygen and nutrients as a result of blood clots.
Read more @ https://digitalgrowinfo.blogspot.com/2022/02/calciphylaxis-treatment-consists-of.html
